Flovent hfa and Victoza drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Flovent hfa and Victoza. Common interactions include cellulitis among females and chronic kidney disease among males.

The phase IV clinical study analyzes what interactions people who take Flovent hfa and Victoza have. It is created by eHealthMe based on reports of 20 people who take Flovent hfa and Victoza from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On May, 26, 2023

20 people who take Flovent hfa and Victoza together, and have interactions are studied.

What is Flovent hfa?

Flovent hfa has active ingredients of fluticasone propionate. It is often used in asthma. eHealthMe is studying from 5,679 Flovent hfa users for its effectiveness, alternative drugs and more.

What is Victoza?

Victoza has active ingredients of liraglutide. It is often used in diabetes. eHealthMe is studying from 40,705 Victoza users for its effectiveness, alternative drugs and more.

Number of Flovent hfa and Victoza reports submitted per year:

Common Flovent Hfa and Victoza drug interactions by gender *:

female:

Cellulitis
Diabetic ketoacidosis
Hospitalisation
Hyperglycaemia
Metabolic acidosis
Pleurisy
Abdominal discomfort
Aphasia
Arthralgia
Blood pressure increased

male:

Chronic kidney disease
Diabetic end stage renal disease
Hyperparathyroidism secondary
Nephrogenic anaemia
Renal failure
Renal injury
Atrial fibrillation
Rehabilitation therapy

Common Flovent Hfa and Victoza drug interactions by age *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

Cellulitis
Pleurisy
Systemic lupus erythematosus
Feeling hot
Flushing
Hospitalisation
Malaise
Pruritus
Stress

50-59:

Renal injury
Diabetic nephropathy
Drug ineffective
Eye swelling
Pain
Urine output increased
Vulvovaginal candidiasis
Chronic kidney disease
Hyperparathyroidism secondary
Pancreatic carcinoma

60+:

Diabetic ketoacidosis
Hyperglycaemia
Metabolic acidosis
Atrial fibrillation

Common conditions people have *:

Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 6 people, 30.00%
Type 2 Diabetes: 5 people, 25.00%
High Blood Pressure: 5 people, 25.00%
Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 5 people, 25.00%
Kidney Stones: 4 people, 20.00%
High Blood Cholesterol: 4 people, 20.00%
Pain: 4 people, 20.00%
Neuropathy Peripheral (surface nerve damage): 4 people, 20.00%
Hypersensitivity: 4 people, 20.00%
Inflammation: 4 people, 20.00%

* Approximation only. Some reports may have incomplete information.

Do you take Flovent hfa and Victoza?

Personalize this study to your gender and age

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related publications that referenced our studies

Lehrer, S., & Rheinstein, P. H. , "Alzheimer’s Disease and Intranasal Fluticasone Propionate in the FDA MedWatch Adverse Events Database", Journal of Alzheimer's disease reports, (Preprint), 1-5., 2018 Jan .
Fontoura P, de Almeida Cardoso MC, Erthal-Martins MC, Werneck C, Sartorio C, Ramos CF, "The effects of liraglutide on male fertility: a case report", Reproductive biomedicine online, 2014 Nov .